首页>Molecular genetics and metabolism>Safety, pharmacokinetics and sialic acid production after oral administration of N -acetylmannosamine (ManNAc) to subjects with GNE myopathy
Safety, pharmacokinetics and sialic acid production after oral administration of N -acetylmannosamine (ManNAc) to subjects with GNE myopathy
作者单位：New Zealand Pharmaceuticals[1]NIH Clinical Center Pharmacy Department, National Institutes of Health[2]Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health[3]Therapeutics for Rare and Neglected Diseases, National Center for Advancing Translational Sciences[4]
换一批
